Purdue Pharma to be sentenced in opioid case, settlement proceeds
Purdue Pharma is set to be sentenced in New Jersey federal court for deceptive marketing and kickbacks related to opioid sales, as part of a plea deal that allows the company to dissolve in bankruptcy and fund a $7.4 billion settlement for victims of the opioid crisis. The company agreed to $5.5 billion in criminal fines, though most will go unpaid, with only $225 million collected by the U.S. Department of Justice.
Topics: Bankruptcy Criminal fines Opioid crisis Purdue Pharma Settlement